Goldline Pharmaceutical Ltd EPS

Goldline Pharmaceutical Ltd EPS

Image

Goldline Pharmaceutical Ltd

NSE: GLPL

EPS

₹ -

Last updated on: Oct 29, 2026

Key Highlights

  • The Earning per Share of Goldline Pharmaceutical Ltd is ₹ 0 as of 29 Oct 26 The earning per share of Goldline Pharmaceutical Ltd changed from ₹ 1 to ₹ 2.18 over 2 quarters. This represents a CAGR of 375.24% .

Historical Earning per Share of Goldline Pharmaceutical Ltd

No data available

* All values are in ₹

Company Fundamentals for Goldline Pharmaceutical Ltd

Market Cap

29 Cr

EPS

0.0

P/E Ratio (TTM)

0.0

P/B Ratio (TTM)

1.3

Day’s High

31.2

Day’s Low

31.2

DTE

0.6

ROE

28.9

52 Week High

60.0

52 Week Low

28.13

ROCE

28.4

Market Price of Goldline Pharmaceutical Ltd

1M

1Y

3Y

5Y

Monitoring Goldline Pharmaceutical Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
29 Oct 202631.2
28 Oct 202630.5
27 Oct 202632.98
26 Oct 202631.99
23 Oct 202630.1
21 Oct 202629.98
19 Oct 202632
16 Oct 202632.48
15 Oct 202631.56
14 Oct 202631.68

BlinkX Score for Goldline Pharmaceutical Ltd

Asset Value vs Market Value of Goldline Pharmaceutical Ltd

Market Value

₹ 30

Asset Value

Value addition

0.1 X

₹ 26

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Goldline Pharmaceutical Ltd29.95
Sun Pharmaceutical Industries Ltd422991
Divis Laboratories Ltd256310
Torrent Pharmaceuticals Ltd173604
Laurus Labs Ltd121300
Zydus Lifesciences Ltd118304

Historical Market Cap of Goldline Pharmaceutical Ltd

No data available

* All values are in ₹ crore

Historical Revenue of Goldline Pharmaceutical Ltd

No data available

* All values are in ₹ crore

Historical EBITDA of Goldline Pharmaceutical Ltd

No data available

* All values are in ₹ crore

Historical Net Profit of Goldline Pharmaceutical Ltd

No data available

* All values are in ₹ crore

Dividend Payout Over Time

No data available

Goldline Pharmaceutical Ltd News Hub

Goldline Pharmaceutical to convene AGM

Goldline Pharmaceutical announced that the Annual General Meeting(AGM) of the company will be held o

Read more

07 Aug 26

BSE SME Goldline Pharmaceutical delivers a dose of listing gains

The scrip was listed at Rs 59.75, a 38.95% premium to the initial public offer (IPO) price. The stoc

Read more

19 May 26

Goldline Pharmaceutical to discuss results

Goldline Pharmaceutical will hold a meeting of the Board of Directors of the Company on 9 June 2026.

Read more

03 Jun 26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Goldline Pharmaceutical Ltd

What is the EPS of Goldline Pharmaceutical Ltd stock?

The Earnings Per Share (EPS) of Goldline Pharmaceutical Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Goldline Pharmaceutical Ltd EPS calculated?

The EPS of Goldline Pharmaceutical Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Goldline Pharmaceutical Ltd report its EPS?

Goldline Pharmaceutical Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Goldline Pharmaceutical Ltd EPS?

Factors that influence the EPS of Goldline Pharmaceutical Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Goldline Pharmaceutical Ltd EPS growth indicate future performance?

Yes, consistent growth in Goldline Pharmaceutical Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions